Fig. 4

An overview of biomarkers for immunotherapy response in breast cancer. TMB, tumor mutational burden; TME, tumor microenvironment; CNA, copy number alterations; dMMR, defects in mismatch repair; MSI, microsatellite instability; POLE, polymerase epsilon; mSAF, maximum somatic allele frequency